Sutro Biopharma, Inc.STRONASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank56
3Y CAGR-11.7%
5Y CAGR+2.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-11.7%/yr
vs +29.2%/yr prior
5Y CAGR
+2.2%/yr
Recent deceleration
Acceleration
-40.9pp
Decelerating
Percentile
P56
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $41.02M | -15.3% |
| 2024 | $48.45M | -22.6% |
| 2023 | $62.58M | +5.1% |
| 2022 | $59.54M | +6.3% |
| 2021 | $56.00M | +52.1% |
| 2020 | $36.82M | +13.0% |
| 2019 | $32.59M | +52.4% |
| 2018 | $21.38M | +30.6% |
| 2017 | $16.37M | +10.5% |
| 2016 | $14.82M | - |